Looks like you clickedhttps://cllsociety.org/2023/02/ash-2022-dr-james-blachly-discusses-results-from-a-phase-1-2-dose-escalation-and-expansion-study-evaluating-ms-533-a-novel-and-selective-protein-kinase-c-beta-inhibitor-in-patients-with-chronic-lym/
If you do not want to visit that page, you can close this browser tab.
